Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

MicroVision Announces Proposed Public Offering of Common Stock
MicroVision Announces Proposed Public Offering of Common Stock

REDMOND, WA / ACCESSWIRE / June 13, 2023 / MicroVision, Inc. (Nasdaq:MVIS), a leader in MEMS-based solid-state automotive lidar technology and ADAS solutions, today announced that it intends

Highly Anticipated Chancer Crypto Presale Officially Launches Today: https://www.valuewalk.com/wp-content/uploads/2023/06/gold-challenge-comp_1372_1686580560dLoepWAWIW-300x180.jpg
Highly Anticipated Chancer Crypto Presale Officially Launches Today

London, United Kingdom, June 13th, 2023, Chainwire

Chancer, one of the most exciting new Web3 projects of 2023 has officially launched its crypto presale today, 13th June. The project aims to

Tax Software Specialist Vertex In Buy Zone After Base Breakout: https://www.valuewalk.com/wp-content/uploads/2023/04/Property-Tax-Credits-from-Maryland-300x150.jpeg
Tax Software Specialist Vertex In Buy Zone After Base Breakout

Key Points

  • Vertex is currently in the buy range after clearing a seven-week consolidation on June 7.
  • Trading volume was more than double the average as the stock cleared resistance above
Tax Software Specialist Vertex In Buy Zone After Base Breakout: https://www.valuewalk.com/wp-content/uploads/2023/04/Property-Tax-Credits-from-Maryland-300x150.jpeg
Tax Software Specialist Vertex In Buy Zone After Base Breakout

Key Points

  • Vertex is currently in the buy range after clearing a seven-week consolidation on June 7.
  • Trading volume was more than double the average as the stock cleared resistance above
Tax Software Specialist Vertex In Buy Zone After Base Breakout: https://www.valuewalk.com/wp-content/uploads/2023/04/Property-Tax-Credits-from-Maryland-300x150.jpeg
Tax Software Specialist Vertex In Buy Zone After Base Breakout

Key Points

  • Vertex is currently in the buy range after clearing a seven-week consolidation on June 7.
  • Trading volume was more than double the average as the stock cleared resistance above
Techtronic Denies Short-Seller Jehoshaphat’s Fraud Allegations in Home Depot Business: https://www.valuewalk.com/wp-content/uploads/2023/02/Home-Depot-Stock-300x150.jpeg
Techtronic Denies Short-Seller Jehoshaphat’s Fraud Allegations in Home Depot Business

A second missive claiming ‘blemished’ channel misdoings are having little impact on Hong Kong-traded shares

Short-seller Jehoshaphat Research (JR) has accused Techtronic Industries (HKG:0669) of

Shareholders Denounce Merck’s Lawsuit Against HHS: https://www.valuewalk.com/wp-content/uploads/2023/06/Merck-Co-300x150.jpeg
Shareholders Denounce Merck’s Lawsuit Against HHS

Shareholders denounce Merck’s lawsuit against HHS as a transparent campaign to protect profits at the expense of patients

Shareholders Deem Merck’s Lawsuit Against HHS As Unconstitutional

NEW

Biognosys stellt innovativen Workflow für tiefgreifende und reproduzierbare Plasma-Proteomik vor und ermöglicht damit Durchbrüche in der Molekulardiagnostik und Medikamentenentwicklung
Biognosys stellt innovativen Workflow für tiefgreifende und reproduzierbare Plasma-Proteomik vor und ermöglicht damit Durchbrüche in der Molekulardiagnostik und Medikamentenentwicklung
  • Der neuartige, durchgängig automatisierte Arbeitsablauf stellt eine neue Methode der Wahl für die massenspektrometrische Single-Shot-Plasmaanalyse ohne Fraktionierung dar
  • Die Bead-basierte
Anhaltend starke Cresemba® (Isavuconazol)-Verkaufszahlen von Pfizer lösen Umsatzmeilensteinzahlungen in Höhe von USD 26 Mio. an Basilea aushttp://www.flickr.com/photos/w0ahitslo/6955091156/sizes/z/in/photostream/: All rights reserved by Queen Beuaroo
Anhaltend starke Cresemba® (Isavuconazol)-Verkaufszahlen von Pfizer lösen Umsatzmeilensteinzahlungen in Höhe von USD 26 Mio. an Basilea aus

Ad hoc-Mitteilung gemäss Art. 53 KR

Allschwil, 08. Juni 2023 

Basilea Pharmaceutica AG, Allschwil (SIX: BSLN), ein biopharmazeutisches Unternehmen mit bereits vermarkteten Produkten und dem Ziel

Anhaltend starke Cresemba® (Isavuconazol)-Verkaufszahlen von Pfizer lösen Umsatzmeilensteinzahlungen in Höhe von USD 26 Mio. an Basilea aushttp://www.flickr.com/photos/w0ahitslo/6955091156/sizes/z/in/photostream/: All rights reserved by Queen Beuaroo
Anhaltend starke Cresemba® (Isavuconazol)-Verkaufszahlen von Pfizer lösen Umsatzmeilensteinzahlungen in Höhe von USD 26 Mio. an Basilea aus

Ad hoc-Mitteilung gemäss Art. 53 KR

Allschwil, 08. Juni 2023 

Basilea Pharmaceutica AG, Allschwil (SIX: BSLN), ein biopharmazeutisches Unternehmen mit bereits vermarkteten Produkten und dem Ziel

OKX Partners with Komainu, Enabling 24/7 Secure Trading of Segregated Assets Under Custody for Institutions: https://mms.businesswire.com/media/20191105005372/en/754182/5/PR_LogoSpec_%282%29.jpg
OKX Partners with Komainu, Enabling 24/7 Secure Trading of Segregated Assets Under Custody for Institutions

ST HELLIER, Jersey, June 6th, 2023, Chainwire

OKX, the world’s second-largest cryptocurrency exchange by trading volume and a leading Web3 technology company, and regulated digital asset custody

Lawmakers Sign Off On Law Enforcement Oversight Reforms: https://www.valuewalk.com/wp-content/uploads/2023/01/Police-300x150.jpeg
Lawmakers Sign Off On Law Enforcement Oversight Reforms

Sunset legislation aims to make fundamental changes to operations at the Texas Commission on Law Enforcement, which oversees licensure of law enforcement.

Building Public Confidence In Law

A Reversal Is Brewing For Medtronic: Buying The Dip: https://www.valuewalk.com/wp-content/uploads/2023/05/Medtronic.jpg
A Reversal Is Brewing For Medtronic: Buying The Dip

Key Points

  • Medtronic had a solid quarter but gave weak guidance, which has shares moving lower. 
  • The company and industry are rebounding from COVID so trends are favorable. 
  • Cautious
Tiziana Life Sciences veranstaltet KOL-Webinar zu Foralumab bei nicht-aktiver sekundär-progredienter Multipler Sklerose (SPMS)
Tiziana Life Sciences veranstaltet KOL-Webinar zu Foralumab bei nicht-aktiver sekundär-progredienter Multipler Sklerose (SPMS)

Das Webinar findet am Montag, den 5. Juni 2023 um 12:30 Uhr ET statt

NEW YORK, May 26, 2023 (GLOBE NEWSWIRE) -- Tiziana Life Sciences Ltd. (Nasdaq: TLSA) („Tiziana“ oder das „Unternehmen“), ein

California Fossil Fuel Divestment Bill ‘SB 252’ Passes Senate With Massive Momentum: https://www.valuewalk.com/wp-content/uploads/2023/05/Sacramento-California-300x150.jpeg
California Fossil Fuel Divestment Bill ‘SB 252’ Passes Senate With Massive Momentum

“It’s not if CalPERS and CalSTRS divest from fossil fuels – it’s when and how fast.”

Indigenous lands of the Nisenan and Miwok Peoples (colonially called Sacramento, California) –  Today, SB 252

Atmos Energy (ATO) Dividend Stock Analysis: https://www.valuewalk.com/wp-content/uploads/2023/05/Dividends-Per-Share.jpg
Atmos Energy (ATO) Dividend Stock Analysis

Atmos Energy Corporation (NYSE:ATO) engages in the regulated natural gas distribution, and pipeline and storage businesses in the United States. It operates in two segments, Distribution, and

Microbot Medical Spikes 150% on its Endovascular Surgical Robot: https://www.valuewalk.com/wp-content/uploads/2023/05/Microbot-Medical.jpg
Microbot Medical Spikes 150% on its Endovascular Surgical Robot

Key Points

  • Microbot Medical makes remote-controlled micro-robotics systems to assist medical practitioners with minimally invasive surgical procedures.
  • Microbot’s LIBERTY robotic system
MorphoSys – Gute Zahlen schüren wieder Vertrauen: https://blog.onemarkets.de/wp-content/uploads/2023/05/20230524_morphosysshort-360x189.png
MorphoSys – Gute Zahlen schüren wieder Vertrauen

Im laufenden Jahr zählt die Aktie von MorphoSys zu den Top-Werten im SDAX®. Ein kleiner Wehrmutstropfen nach einer dreijährigen Talfahrt, bei der die Aktie zeitweise über 90 Prozent verlor. Aufwind

MorphoSys – Gute Zahlen schüren wieder Vertrauen: https://blog.onemarkets.de/wp-content/uploads/2023/05/20230524_morphosysshort-360x189.png
MorphoSys – Gute Zahlen schüren wieder Vertrauen

Im laufenden Jahr zählt die Aktie von MorphoSys zu den Top-Werten im SDAX®. Ein kleiner Wehrmutstropfen nach einer dreijährigen Talfahrt, bei der die Aktie zeitweise über 90 Prozent verlor. Aufwind

Vertex Labs Acquires Digimental Studio For Us$12 Millionhttp://www.xconomy.com/wordpress/wp-content/images/2010/08/VertexPharma.png: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/12180/VertexPharma.png
Vertex Labs Acquires Digimental Studio For Us$12 Million

LONDON, UNITED KINGDOM, May 23rd, 2023, Chainwire

Vertex Labs (Vertexlabs.uk), the brain behind the Caduceus metaverse protocol, Vertex Network and 3D metaverse platform, LightCycle, has acquired

Vertex Labs Acquires Digimental Studio For Us$12 Millionhttp://www.xconomy.com/wordpress/wp-content/images/2010/08/VertexPharma.png: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/12180/VertexPharma.png
Vertex Labs Acquires Digimental Studio For Us$12 Million

LONDON, UNITED KINGDOM, May 23rd, 2023, Chainwire

Vertex Labs (Vertexlabs.uk), the brain behind the Caduceus metaverse protocol, Vertex Network and 3D metaverse platform, LightCycle, has acquired

Vertex Labs Acquires Digimental Studio For Us$12 Millionhttp://www.xconomy.com/wordpress/wp-content/images/2010/08/VertexPharma.png: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/12180/VertexPharma.png
Vertex Labs Acquires Digimental Studio For Us$12 Million

LONDON, UNITED KINGDOM, May 23rd, 2023, Chainwire

Vertex Labs (Vertexlabs.uk), the brain behind the Caduceus metaverse protocol, Vertex Network and 3D metaverse platform, LightCycle, has acquired

Zoetis Declares New Dividend, Hinting At Undervaluation: https://www.valuewalk.com/wp-content/uploads/2023/02/Zoetis-Stock-300x150.jpeg
Zoetis Declares New Dividend, Hinting At Undervaluation

Key Points

  • JAB has announced its plans to acquire Pumpkin, a pet insurance platform launched by Zoetis, which is still a minority holder.
  • As Zoetis undertakes its plans for sustainable
XBiotech startet Kaufangebot im Wert von bis zu 80.000.000 USD für seine Aktien
XBiotech startet Kaufangebot im Wert von bis zu 80.000.000 USD für seine Aktien

AUSTIN, Texas, May 18, 2023 (GLOBE NEWSWIRE) -- Xbiotech Inc. (NASDAQ: XBIT) („Xbiotech“) gab heute bekannt, dass es ein Kaufangebot im Rahmen einer „modifizierten holländischen Auktion“ für den

Cyber Insurance Is Important In Both War And Peace: https://www.valuewalk.com/wp-content/uploads/2023/05/Cyber-Insurance-300x150.jpeg
Cyber Insurance Is Important In Both War And Peace

The new fine print in wartime cyber insurance has thrown a wrench in the works. Many boards of directors are struggling to understand it. Yet, cyber insurance is just one part of the fintech puzzle